1-8 of 8
Ziyu Wen
Close
Sort by
Journal Articles

Analysis the Relationship between Clonal Hematopoiesis and Cardiovascular Events in Chronic Myeloid Leukemia Based on Next-Generation Sequencing Technology

Jie Luo, Ziyu Wen, Mengxia Zhao, Zicheng Gao, Hong Chen, Qiang Wang, Xuan Zhou, Zherou He, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Qifa Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1796.
https://doi.org/10.1182/blood-2023-182007
Published: 2023
Journal Articles

Single-Cell RNA Sequencing Uncovers Abnormal Differentiation of Neutrophil and Megakaryocyte Might Mediated Ruxolitinib Resistance for Patinets with PMF

Na Xu, Hanyin Liang, Dongmei Luo, Ziyu Wen, Zicheng Gao, Zherou He, Hong Chen, Xiaoli Liu, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6341.
https://doi.org/10.1182/blood-2023-184551
Published: 2023
Journal Articles

Flumatinib for the Treatment of Adult Patients with Resistant or Intolerant Chronic-Phase Chronic Myeloid Leukemia: Results from Real-World Data

Xuan Zhou, Na Xu, Ziyu Wen, Hanyin Liang, Dongmei Luo, Hong Chen, Zherou He, Zicheng Gao, Qiang Wang, Dan Xu, Xiaoli Liu, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6379.
https://doi.org/10.1182/blood-2023-184643
Published: 2023
Journal Articles

TKI Dose Optimization Based on Therapeutic Drug Monitoringļ¼ˆTDM) with Encouraging Outcomes and Well-Tolerated for Chronic Myeloid Leukaemia Patients

Zherou He, Xuan Zhou, Ziyu Wen, Zicheng Gao, Hong Chen, Qiang Wang, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Na Xu, Qifa Liu
Journal: Blood
Blood (2023) 142 (Supplement 1): 1807.
https://doi.org/10.1182/blood-2023-182765
Published: 2023
Journal Articles

Ruxolitinib or Interferon-Ī± Treatment As a Protective Strategy for Patients with Philadelphia-Negative Myeloproliferative Neoplasms (MPN) during the COVID-19 Pandemic

Zicheng Gao, Zherou He, Xuan Zhou, Ziyu Wen, Hong Chen, Qiang Wang, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Qifa Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 6411.
https://doi.org/10.1182/blood-2023-184700
Published: 2023
Journal Articles

Flumatinib for Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: An Open-Label, Multi-Center Study

Ziyu Wen, Ying Zhao, Guowei Li, YongZhong Su, FeiHeng Chen, HongFang Tao, ZhengJin Zheng, Wuqiang Lin, XiuLi Chen, Meili Meng, Lian Yu, LongTian Chen, JianQing Huang, Guocai Wu, Mengxia Zhao, Zhenfang Liu, Hongqian Zhu, Yirong Jiang, Qifa Liu, Xiaoli Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 3175.
https://doi.org/10.1182/blood-2023-181456
Published: 2023
Journal Articles

Olverembatinib(HQP1351)-Based Therapy in Adults with Relapsed or Refractory Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia or Advanced Chronic Myeloid Leukemia: Results of the Real-Life Study

Ziyu Wen, Zhiping Fan, Qiang Wang, Xuan Zhou, Zherou He, Zicheng Gao, Hong Chen, Hanyin Liang, Dongmei Luo, Xiaoli Liu, Hongsheng Zhou, Qifa Liu, Na Xu
Journal: Blood
Blood (2023) 142 (Supplement 1): 4538.
https://doi.org/10.1182/blood-2023-181850
Published: 2023
Journal Articles

Outcomes of Olverembatinib Based Regimen in Patients with Philadelphia Chromosome-Positive Advanced Leukemias: A Real-World, Single-Center Experience

Ziyu Wen, Xuan Zhou, Zhiping Fan, Qifa Liu, Jing Sun, Xiaoli Liu, Na Xu
Journal: Blood
Blood (2022) 140 (Supplement 1): 12217.
https://doi.org/10.1182/blood-2022-164569
Published: 2022